David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 311,392 shares at $1.64 ($12K) on 2018-10-29, disclosed to the SEC on 2018-10-31.
Scheduled sale ($12k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 227,576 | $0 | 0.0% |
| 2 | $0.00 | 76,401 | $0 | 0.0% |
| 3 | $1.64 | 222 | $364 | 3.0% |
| 4 | $1.64 | 482 | $790 | 6.5% |
| 5 | $1.64 | 6,711 | $11K | 90.5% |
| Total | $0.04 avg | 311,392 |
| $12K |
| 100% |
| Filing → |
| GEN | SELL | 2018-11-15 | $53K | — | Filing → |
| GEN | SELL | 2018-11-13 | $73K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |